These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 16470316)
21. 2% dorzolamide and cornea: an ultrabiomicroscopic study. Uva MG; Russo V; Longo A; Ott JP; Reibaldi A Acta Ophthalmol Scand Suppl; 1997; (224):23-4. PubMed ID: 9589715 [No Abstract] [Full Text] [Related]
22. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. Sugrue MF J Ocul Pharmacol Ther; 1996; 12(3):363-76. PubMed ID: 8875343 [TBL] [Abstract][Full Text] [Related]
23. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension. Gugleta K Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146 [TBL] [Abstract][Full Text] [Related]
29. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension. Jansook P; Stefánsson E; Thorsteinsdóttir M; Sigurdsson BB; Kristjánsdóttir SS; Bas JF; Sigurdsson HH; Loftsson T Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867 [TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic equivalence study of two preparations of eye drops containing dorzolamide and timolol in healthy volunteers. Gatchev E; Petrov A; Kolev E; Hristova R; Demircheva I; Koytchev R; Richter W; Tegel F; Thyroff-Friesinger U Arzneimittelforschung; 2011; 61(5):282-6. PubMed ID: 21755811 [TBL] [Abstract][Full Text] [Related]
31. [Comparative study of the pressure lowering efficacy and variations in the ocular pulse amplitude between fixed combinations of dorzolamide/timolol and brinzolamide/timolol]. Sánchez-Pulgarín M; Martínez-de-la-Casa JM; García-Feijoó J; Sáenz-Francés F; Santos-Bueso E; Herrero-Vanrell R; García Sánchez J Arch Soc Esp Oftalmol; 2011 May; 86(5):149-53. PubMed ID: 21624655 [TBL] [Abstract][Full Text] [Related]
32. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma. Scardillo A; Pugliese M; De Majo M; Niutta PP; Pugliese A Vet Ther; 2010; 11(3):E1-6. PubMed ID: 20960417 [TBL] [Abstract][Full Text] [Related]
33. Central corneal thickness in the European Glaucoma Prevention Study. ; Pfeiffer N; Torri V; Miglior S; Zeyen T; Adamsons I; Cunha-Vaz J Ophthalmology; 2007 Mar; 114(3):454-9. PubMed ID: 17126403 [TBL] [Abstract][Full Text] [Related]
34. Topical drug delivery to the eye: dorzolamide. Loftsson T; Jansook P; Stefánsson E Acta Ophthalmol; 2012 Nov; 90(7):603-8. PubMed ID: 22269010 [TBL] [Abstract][Full Text] [Related]
35. [Blurred vision after instillation of topical carbonic anhydrase inhibitor]. Ishibashi T; Mori K Nippon Ganka Gakkai Zasshi; 2006 Sep; 110(9):689-92. PubMed ID: 17025224 [TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacokinetics of dorzolamide. Martens-Lobenhoffer J; Banditt P Clin Pharmacokinet; 2002; 41(3):197-205. PubMed ID: 11929320 [TBL] [Abstract][Full Text] [Related]
37. Retrobulbar hemodynamics before and after oculopression with and without dorzolamide. Huber-van der Velden KK; Lux A; Severing K; Klamann MK; Winterhalter S; Remky A Curr Eye Res; 2012 Aug; 37(8):719-25. PubMed ID: 22642452 [TBL] [Abstract][Full Text] [Related]
38. [Effect of dorzolamide on accommodation and pupillary reaction?]. Pek H; Wilhelm H Ophthalmologe; 2000 Nov; 97(11):769-73. PubMed ID: 11130166 [TBL] [Abstract][Full Text] [Related]
39. Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration. Sigurdsson HH; Stefánsson E; Gudmundsdóttir E; Eysteinsson T; Thorsteinsdóttir M; Loftsson T J Control Release; 2005 Jan; 102(1):255-62. PubMed ID: 15653150 [TBL] [Abstract][Full Text] [Related]
40. Optic nerve oxygen tension: effects of intraocular pressure and dorzolamide. la Cour M; Kiilgaard JF; Eysteinsson T; Wiencke AK; Bang K; Dollerup J; Jensen PK; Stefánsson E Br J Ophthalmol; 2000 Sep; 84(9):1045-9. PubMed ID: 10966963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]